About us
Founded in 2012 and granted the qualification of biomedicine company by the Ministry of Economic Affairs in 2015, Energenesis Biomedical Co., Ltd. aspires to become a new star in biotech industry.
Information
- 2018-03 Capital increment in cash by NT$ 210 million
- 2018-03 The IND application of ENERGI-F701 Phase II trial for female pattern hair loss (FPHL) have been approved by TFDA.
- 2018-02 The IND application of ENERGI-F701 Phase II trial for female pattern hair loss (FPHL) have been noticed by FDA to proceed.
- 2018-01 The US 858, 954 patent is granted.
- 2017-11 The Japanese patent, 活性化ａｍｐｋの化合物及びその使用 (JP6254263B2), is granted.